Dental Biomaterials Market Size, Share, Growth Analysis, By Type(Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials), By End-use(Dental Hospitals and Clinics, Dental Laboratories, Dental Academies and Research Institutes, and Dental Product Manufacturers), By Region - Industry Forecast 2024-2031

Dental Biomaterials Market size was valued at USD 8.26 Billion in 2022 and is poised to grow from USD 8.86 Billion in 2023 to USD 15.56 Billion by 2031, at a CAGR of 7.29% during the forecast period (2024-2031).

The competitive landscape of the global dental biomaterial market is characterized by intense competition and a diverse range of players. The market is highly fragmented, with several established manufacturers and emerging players vying for market share. Key players in the market focus on product development, technological advancements, strategic partnerships, and acquisitions to strengthen their market position. The market is driven by innovation, with companies constantly introducing new and advanced dental biomaterial products to meet the evolving needs of dental professionals and patients. Additionally, the market is influenced by factors such as pricing strategies, distribution channels, brand reputation, and regulatory compliance. Overall, the global dental biomaterial market presents numerous growth opportunities for both established and new entrants, as the demand for dental biomaterials continues to rise globally. 'Straumann Holding AG (Switzerland)', 'DENTSPLY SIRONA Inc. (United States)', 'Danaher Corporation (United States)', '3M Company (United States)', 'Zimmer Biomet Holdings, Inc. (United States)', 'Henry Schein, Inc. (United States)', 'Ivoclar Vivadent AG (Liechtenstein)', 'Kuraray Noritake Dental Inc. (Japan)', 'GC Corporation (Japan)', 'Nobel Biocare Services AG (Switzerland)', 'Mitsui Chemicals, Inc. (Japan)', 'Coltene Holding AG (Switzerland)', 'Dentium Co., Ltd. (South Korea)', 'VOCO GmbH (Germany)', 'Medtronic plc (Ireland)', 'Septodont Holding (France)', 'KaVo Kerr (United States)', 'Ultradent Products, Inc. (United States)', 'Shofu Dental Corporation (Japan)', 'Planmeca Oy (Finland)'

Advances in dental technology, such as CAD/CAM systems, 3D printing, and digital dentistry, have revolutionized dental procedures. These technological advancements have improved the precision, efficiency, and aesthetics of dental restorations, fueling the demand for dental biomaterials.

Increasing Dental Tourism: Dental tourism, where individuals travel to other countries for dental treatments, has been on the rise. This trend is driven by factors such as lower treatment costs, high-quality dental care, and shorter waiting times. Dental biomaterials play a significant role in providing affordable and effective dental treatments, contributing to the growth of the market.

North America was the dominant market for dental biomaterials, accounting for a market share of 35.5%. This is expected to continue over the forecast period, due to factors such as growing government expenditure on oral health, rising aging population, and increasing adoption of dental biomaterials for the production of dental products and implants. The rising number of dental hospitals and clinics is also a contributing factor to the growth of the market in this region.